Antibodies pay Toll to improve their therapeutic efficacy: improving antibody-mediated anticancer treatment via co-activation of Fc-receptors and Toll-like receptors
Author(s):
Ganzevles, S.; Stigter-van Walsum, M.; Schilham, M.; Tuk, K.; Egmond, M. van; Leemans, R.; Brakenhoff, R.; Bakema, J.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-08-31
Language
English
Is part of
European Journal of Immunology (2016), Vol. 46, p. 204-204
